TickerFactsScreenerDevelopers

Aldeyra Therapeutics, Inc. (ALDX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $1.22M2013: $3.26M2014: $8.53M2015: $14.65M2016: $12.02M2017: $20.02M2018: $47.36M2019: $44.43M2020: $77.86M2021: $229.79M2022: $144.42M2024: $54.53M2025: $70.04M$70.04M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$70.04M+28.5%
2024$54.53M—
2022$144.42M-37.2%
2021$229.79M+195.1%
2020$77.86M+75.3%
2019$44.43M-6.2%
2018$47.36M+136.5%
2017$20.02M+66.7%
2016$12.02M-18.0%
2015$14.65M+71.8%
2014$8.53M+161.4%
2013$3.26M+166.6%
2012$1.22M—